HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Fujifilm Launches Highly-Sensitive, Rapid CE-Marked SARS-CoV-2 Antigen Test Based on Silver Halide Amplification Technology

By HospiMedica International staff writers
Posted on 16 Mar 2021
Print article
Image
Image
FUJIFILM Europe GmbH (Duesseldorf, Germany) has launched a new antigen test kit for the diagnosis of SARS-CoV-2 infection that has received the CE certificate and utilizes its proprietary silver amplification immunochromatography method.

Since 2011, Fujifilm has marketed rapid diagnostic testing equipment and reagents for influenza and other infectious diseases, using the proprietary "silver amplification immunochromatography method" which is based on silver amplification technology used in the photo-developing process, to enhance results' sensitivity and speed. The system has been adopted by numerous medical institutions in Japan as a high-sensitivity antigen test capable of detecting viruses even when viral load is low at the onset of a disease. Fujifilm has found that even with SARS-CoV-2 antigen, a highly sensitive antigen test is feasible with the application of silver amplification immunochromatography.

The company has developed the FUJIFILM COVID-19 Ag Test, an antigen test kit that can rapidly and sensitively examine the presence of SARS-CoV-2 antigens in specimens, detecting the virus at an early stage and in view of a relatively low viral load. Fast results are produced within 10-13 minutes. The Fujifilm rapid antigen test uses nasopharyngeal swab samples and can be performed within the community as well as clinical settings, which enables a faster result than the current laboratory tests.

"During the pandemic Fujifilm supported the global healthcare community in the complex management of the emergency," said Mr. Masaharu Fukumoto, Senior Vice President FUJIFILM Europe GmbH Medical Systems Division. "It did so through its diagnostic and IT/AI solutions so that COVID-19 patients could be treated with the utmost care and precision. Today we can provide further support for the early detection of COVID-19, through a rapid antigen test that can provide a highly sensitive result for early detection. We used our proprietary silver amplification immunochromatographic method, that amplifies signal particles more than 100 times and increases the sensitivity, and has the potential to enhance detection in more asymptomatic patients carrying the COVID-19 virus an at an early stage."




Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Video Laryngoscope
SH-VL1

Print article

Channels

Critical Care

view channel
Image: The new risk assessment tool determines patient-specific risks of developing unfavorable outcomes with heart failure (Photo courtesy of 123RF)

Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients

Heart failure is a serious condition where the heart cannot pump sufficient blood to meet the body's needs, leading to symptoms like fatigue, weakness, and swelling in the legs and feet, and it can ultimately... Read more

Surgical Techniques

view channel
Image: The multi-sensing device can be implanted into blood vessels to help physicians deliver timely treatment (Photo courtesy of IIT)

Miniaturized Implantable Multi-Sensors Device to Monitor Vessels Health

Researchers have embarked on a project to develop a multi-sensing device that can be implanted into blood vessels like peripheral veins or arteries to monitor a range of bodily parameters and overall health status.... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more